John Overdeck’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.57M | Sell |
6,600
-4,300
| -39% | -$894K | ﹤0.01% | 3224 |
|
|
2026
Q1 | $2.3M | Buy |
+10,900
| New | +$2.35M | ﹤0.01% | 2649 |
|
|
2022
Q1 | – | Sell |
-50,100
| Closed | -$2.58M | – | 2856 |
|
|
2021
Q4 | $2.58M | Buy |
50,100
+7,100
| +17% | +$348K | 0.01% | 1706 |
|
|
2021
Q3 | $2.13M | Buy |
43,000
+25,000
| +139% | +$1.36M | ﹤0.01% | 1928 |
|
|
2021
Q2 | $1.03M | Buy |
18,000
+1,800
| +11% | +$105K | ﹤0.01% | 2456 |
|
|
2021
Q1 | $984K | Sell |
16,200
-5,300
| -25% | -$293K | ﹤0.01% | 2338 |
|
|
2020
Q4 | $1.15M | Buy |
21,500
+10,500
| +95% | +$545K | ﹤0.01% | 1883 |
|
|
2020
Q3 | $516K | Buy |
11,000
+3,900
| +55% | +$200K | ﹤0.01% | 2228 |
|
|
2020
Q2 | $371K | Sell |
7,100
-16,600
| -70% | -$856K | ﹤0.01% | 2225 |
|
|
2020
Q1 | $1.14M | Buy |
23,700
+13,800
| +139% | +$717K | 0.01% | 1317 |
|
|
2019
Q4 | $501K | Sell |
9,900
-5,900
| -37% | -$305K | ﹤0.01% | 2798 |
|
|
2019
Q3 | $746K | Sell |
15,800
-25,700
| -62% | -$1.17M | ﹤0.01% | 2228 |
|
|
2019
Q2 | $1.96M | Buy |
41,500
+20,500
| +98% | +$946K | 0.01% | 1454 |
|
|
2019
Q1 | $1.01M | Buy |
21,000
+14,400
| +218% | +$721K | ﹤0.01% | 1819 |
|
|
2018
Q4 | $294K | Sell |
6,600
-38,900
| -85% | -$2.03M | ﹤0.01% | 2461 |
|
|
2018
Q3 | $2.46M | Buy |
45,500
+24,500
| +117% | +$1.25M | 0.01% | 1339 |
|
|
2018
Q2 | $1.02M | Sell |
21,000
-8,300
| -28% | -$471K | ﹤0.01% | 2132 |
|
|
2018
Q1 | $1.84M | Buy |
29,300
+14,300
| +95% | +$981K | 0.01% | 1583 |
|
|
2017
Q4 | $919K | Buy |
+15,000
| New | +$927K | ﹤0.01% | 2030 |
|
|
2017
Q3 | – | Sell |
-11,300
| Closed | -$880K | – | 2756 |
|
|
2017
Q2 | $880K | Buy |
+11,300
| New | +$853K | ﹤0.01% | 1979 |
|
|
2016
Q4 | – | Sell |
-18,500
| Closed | -$1.44M | – | 3116 |
|
|
2016
Q3 | $1.44M | Buy |
18,500
+11,300
| +157% | +$913K | 0.01% | 1710 |
|
|
2016
Q2 | $562K | Sell |
7,200
-2,800
| -28% | -$223K | ﹤0.01% | 2167 |
|
|
2016
Q1 | $820K | Sell |
10,000
-72,000
| -88% | -$5.85M | ﹤0.01% | 1720 |
|
|
2015
Q4 | $7.32M | Buy |
+82,000
| New | +$6.96M | 0.04% | 529 |
|
|
2015
Q2 | – | Sell |
-3,000
| Closed | -$271K | – | 2808 |
|
|
2015
Q1 | $271K | Buy |
+3,000
| New | +$258K | ﹤0.01% | 2326 |
|
Other funds holding CAH
John Overdeck's CAH Position: Q2 2026 in Review
John Overdeck reduced its Cardinal Health (CAH) stake by 100% in Q2 2026, selling an estimated $91.1M and leaving 1,400 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #4458.
John Overdeck first reported a position in CAH in Q4 2013 and has held it in 42 quarters since. The position peaked at $168M in Q2 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- John Overdeck held 1,400 shares of Cardinal Health worth $333K as of Q2 2026.
- John Overdeck sold 438,483 Cardinal Health shares in Q2 2026, an estimated $91.1M.
- Cardinal Health made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4458 holding.
- John Overdeck first reported a position in Cardinal Health in Q4 2013 and has held it in 42 quarters since.
- John Overdeck's Cardinal Health position peaked at $168M in Q2 2025.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.